Re-biopsy by endobronchial ultrasound procedures for mutation analysis of non-small cell lung cancer after EGFR tyrosine kinase inhibitor treatment

BACKGROUND: Re-biopsy for resistant non-small cell lung cancer (NSCLC) after treatment with epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) is important for selection of better therapy, but there have been no reports about the utility of endobronchial ultrasound (EBUS)-guided...

Descripción completa

Detalles Bibliográficos
Autores principales: Izumo, Takehiro, Matsumoto, Yuji, Chavez, Christine, Tsuchida, Takaaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4960795/
https://www.ncbi.nlm.nih.gov/pubmed/27457475
http://dx.doi.org/10.1186/s12890-016-0268-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4960795/
https://www.ncbi.nlm.nih.gov/pubmed/27457475
http://dx.doi.org/10.1186/s12890-016-0268-3

Ejemplares similares